Logiscreen

Stereotaxis Inc

$1.78
Market Cap 173.10M
ROE -258.1%
Gross Margin 60.3%
Debt/Equity 0.4
Current Ratio 1.6
Revenue QoQ -15.8%
EPS QoQ -0.1%
F-Score 5

About

Stereotaxis is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 150,000 patients across the United States, Europe, Asia, and elsewhere.

Exchange
AMEX
Sector
Healthcare
Industry
Medical Instruments & Supplies

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-7.97
vs median 31.50
P/B
12.73
vs median 2.17
ROE
-2.58
vs median 0.09

Decent quality with acceptable fundamentals

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics